Revolution Medicines, Inc. 4

Lorence H. Kim, via the Lorence Kim Revocable Trust, sold about 17,090 shares of Revolution Medicines (RVMD) common stock on September 8, 2026 for roughly $3.6 million under a 10b5-1 plan.

On September 8, 2026, Lorence H. Kim, through the Lorence Kim Revocable Trust, executed a series of open-market sales of Revolution Medicines, Inc. (RVMD) common stock under a Rule 10b5-1 trading plan adopted on June 1, 2026. The trust sold a total of 17,090 shares in multiple tranches at weighted average prices ranging from approximately $206.60 to $212.27 per share, generating aggregate proceeds of roughly $3.6 million. Following these disposition transactions, the trust’s direct ownership in RVMD common stock reported on this Form 4 was reduced to zero shares, while the filing notes that the reporting person also has 1,191 restricted stock units outstanding. The trades were executed in multiple smaller lots within specified price ranges, and the reporting person has undertaken to provide detailed trade breakdowns upon request.

Filing Facts

CIK

1628171

Ticker

RVMD

Form

4

Source Type

fda

Accession

0001193125-26-388156

Alert Tier

7